These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35462077)

  • 1. Claudin-1 mediates progression by regulating EMT through AMPK/TGF-β signaling in head and neck squamous cell carcinoma.
    Chang JW; Seo ST; Im MA; Won HR; Liu L; Oh C; Jin YL; Piao Y; Kim HJ; Kim JT; Jung SN; Koo BS
    Transl Res; 2022 Sep; 247():58-78. PubMed ID: 35462077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLDN1 induces autophagy to promote proliferation and metastasis of esophageal squamous carcinoma through AMPK/STAT1/ULK1 signaling.
    Wu J; Gao F; Xu T; Li J; Hu Z; Wang C; Long Y; He X; Deng X; Ren D; Zhou B; Dai T
    J Cell Physiol; 2020 Mar; 235(3):2245-2259. PubMed ID: 31498437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells.
    Suh Y; Yoon CH; Kim RK; Lim EJ; Oh YS; Hwang SG; An S; Yoon G; Gye MC; Yi JM; Kim MJ; Lee SJ
    Oncogene; 2013 Oct; 32(41):4873-82. PubMed ID: 23160379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FSCN1 is upregulated by SNAI2 and promotes epithelial to mesenchymal transition in head and neck squamous cell carcinoma.
    Wang L; Jia Y; Jiang Z; Gao W; Wang B
    Cell Biol Int; 2017 Aug; 41(8):833-841. PubMed ID: 28488774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withaferin A mitigates metastatic traits in human oral squamous cell carcinoma caused by aberrant claudin-1 expression.
    Shin JA; Kim LH; Ryu MH; Choi SY; Jin B; Lee W; Jung YC; Ahn CH; Ahn MH; Hong KO; Swarup N; Chawla K; Kang SC; Hong SD; Cho SD
    Cell Biol Toxicol; 2022 Feb; 38(1):147-165. PubMed ID: 33665778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma.
    Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J
    Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.
    Huang T; Huang W; Lu H; Zhang BY; Ma J; Zhao D; Wang YJ; Yu DH; He X
    J Transl Med; 2018 Feb; 16(1):46. PubMed ID: 29490660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma.
    Gluck C; Glathar A; Tsompana M; Nowak N; Garrett-Sinha LA; Buck MJ; Sinha S
    PLoS Genet; 2019 Jul; 15(7):e1008250. PubMed ID: 31306413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKCδ-iPLA2-PGE2-PPARγ signaling cascade mediates TNF-α induced Claudin 1 expression in human lung carcinoma cells.
    Iitaka D; Moodley S; Shimizu H; Bai XH; Liu M
    Cell Signal; 2015 Mar; 27(3):568-77. PubMed ID: 25562426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the TGF-β1/EMT signaling pathway by claudin-1 overexpression reduces doxorubicin sensitivity in small cell lung cancer SBC-3 cells.
    Nagaoka Y; Oshiro K; Yoshino Y; Matsunaga T; Endo S; Ikari A
    Arch Biochem Biophys; 2024 Jan; 751():109824. PubMed ID: 37984759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker Potential of
    Ju Y; Zhu F; Fang B
    Int J Med Sci; 2024; 21(5):921-936. PubMed ID: 38617010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPK Inhibits the Stimulatory Effects of TGF-β on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition.
    Lin H; Li N; He H; Ying Y; Sunkara S; Luo L; Lv N; Huang D; Luo Z
    Mol Pharmacol; 2015 Dec; 88(6):1062-71. PubMed ID: 26424816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulation.
    Saxena M; Balaji SA; Deshpande N; Ranganathan S; Pillai DM; Hindupur SK; Rangarajan A
    J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29950484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin attenuates the epithelial-mesenchymal transition of lens epithelial cells through the AMPK/TGF-β/Smad2/3 signalling pathway.
    Wang L; Tian Y; Shang Z; Zhang B; Hua X; Yuan X
    Exp Eye Res; 2021 Nov; 212():108763. PubMed ID: 34517004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer.
    Hwang KE; Kim HJ; Song IS; Park C; Jung JW; Park DS; Oh SH; Kim YS; Kim HR
    Int J Med Sci; 2021; 18(3):715-726. PubMed ID: 33437206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
    Huang J; Liang B; Wang T
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLDN1 expression in cervical cancer cells is related to tumor invasion and metastasis.
    Zhang WN; Li W; Wang XL; Hu Z; Zhu D; Ding WC; Liu D; Li KZ; Ma D; Wang H
    Oncotarget; 2016 Dec; 7(52):87449-87461. PubMed ID: 27974683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WISP1 aggravates cell metastatic potential by abrogating TGF-
    Song D; Wang L; Su K; Wu H; Li J
    Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.